(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HALDA THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

HALDA THERAPEUTICS

ST13

US500000097330340

Class

42

Filing

97330340

Registration

7053001

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

04/04/2026

Trademark type

Combined

Nice classes

42

Filing date

03/25/2022

Registration date

05/16/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/16/2023

Last transaction

04/04/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/07/2022

First use in commerce

11/07/2022

Drawing code

3

Owner type

03

Owner location

New Haven, CT, US

Examiner

HUSSAIN, TASNEEM

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of HALDA stylized including a square and triangle, under which is THERAPEUTICS stylized.

Holders and representatives

Holders

Halda Therapeutics OpCo, Inc.

Representatives

Danielle Rivera JOHNSON & JOHNSON

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Biochemical research and development; Medical research; Pharmaceutical research and development; Research and development in the field of pharmaceuticalsgeneticstherapeuticsdrug formulation and delivery; Research and development of vaccines and medicines; Scientific research; Scientific research and development; Scientific research in the field of pharmaceuticalsmedicinedisease treatment

Publications

History of USPTO decisions and trademark events.

27 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/02/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/02/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/02/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/02/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/02/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/02/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/16/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/16/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/28/2023

PUBO

PUBLISHED FOR OPPOSITION

02/28/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/08/2023

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

01/24/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/23/2023

IUAA

USE AMENDMENT ACCEPTED

01/23/2023

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

01/18/2023

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

01/18/2023

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

01/14/2023

IUAF

USE AMENDMENT FILED

01/14/2023

EAAU

TEAS AMENDMENT OF USE RECEIVED

01/13/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

01/11/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/11/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

01/11/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/11/2023

DOCK

ASSIGNED TO EXAMINER

01/10/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/31/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/30/2022

NWAP

NEW APPLICATION ENTERED

03/29/2022

Continuous trademark protection

Get notified about every new filing that threatens HALDA THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.